vs
Apellis Pharmaceuticals, Inc.（APLS）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.6倍（$324.4M vs $199.9M），Revolve Group, Inc.净利率更高（5.7% vs -29.5%，领先35.2%），Revolve Group, Inc.同比增速更快（10.4% vs -5.9%），Revolve Group, Inc.自由现金流更多（$-13.3M vs $-14.3M），过去两年Revolve Group, Inc.的营收复合增速更高（9.5% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
APLS vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.6倍
$199.9M
营收增速更快
RVLV
高出16.4%
-5.9%
净利率更高
RVLV
高出35.2%
-29.5%
自由现金流更多
RVLV
多$998.0K
$-14.3M
两年增速更快
RVLV
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $324.4M |
| 净利润 | $-59.0M | $18.6M |
| 毛利率 | — | 53.3% |
| 营业利润率 | -25.6% | 6.3% |
| 净利率 | -29.5% | 5.7% |
| 营收同比 | -5.9% | 10.4% |
| 净利润同比 | -62.2% | 50.4% |
| 每股收益（稀释后） | $-0.40 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSRVLV
| Q4 25 | $199.9M | $324.4M | ||
| Q3 25 | $458.6M | $295.6M | ||
| Q2 25 | $178.5M | $309.0M | ||
| Q1 25 | $166.8M | $296.7M | ||
| Q4 24 | $212.5M | $293.7M | ||
| Q3 24 | $196.8M | $283.1M | ||
| Q2 24 | $199.7M | $282.5M | ||
| Q1 24 | $172.3M | $270.6M |
净利润APLSRVLV
| Q4 25 | $-59.0M | $18.6M | ||
| Q3 25 | $215.7M | $21.2M | ||
| Q2 25 | $-42.2M | $10.2M | ||
| Q1 25 | $-92.2M | $11.8M | ||
| Q4 24 | $-36.4M | $12.3M | ||
| Q3 24 | $-57.4M | $11.0M | ||
| Q2 24 | $-37.7M | $15.4M | ||
| Q1 24 | $-66.4M | $10.9M |
毛利率APLSRVLV
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
营业利润率APLSRVLV
| Q4 25 | -25.6% | 6.3% | ||
| Q3 25 | 48.7% | 7.1% | ||
| Q2 25 | -18.6% | 5.8% | ||
| Q1 25 | -50.0% | 5.0% | ||
| Q4 24 | -12.3% | 3.9% | ||
| Q3 24 | -24.0% | 5.0% | ||
| Q2 24 | -14.7% | 5.8% | ||
| Q1 24 | -36.0% | 3.4% |
净利率APLSRVLV
| Q4 25 | -29.5% | 5.7% | ||
| Q3 25 | 47.0% | 7.2% | ||
| Q2 25 | -23.6% | 3.3% | ||
| Q1 25 | -55.3% | 4.0% | ||
| Q4 24 | -17.1% | 4.2% | ||
| Q3 24 | -29.2% | 3.9% | ||
| Q2 24 | -18.9% | 5.4% | ||
| Q1 24 | -38.5% | 4.0% |
每股收益（稀释后）APLSRVLV
| Q4 25 | $-0.40 | $0.27 | ||
| Q3 25 | $1.67 | $0.29 | ||
| Q2 25 | $-0.33 | $0.14 | ||
| Q1 25 | $-0.74 | $0.16 | ||
| Q4 24 | $-0.30 | $0.18 | ||
| Q3 24 | $-0.46 | $0.15 | ||
| Q2 24 | $-0.30 | $0.21 | ||
| Q1 24 | $-0.54 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $512.5M |
| 总资产 | $1.1B | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSRVLV
| Q4 25 | $466.2M | $292.3M | ||
| Q3 25 | $479.2M | $315.4M | ||
| Q2 25 | $370.0M | $310.7M | ||
| Q1 25 | $358.4M | $300.8M | ||
| Q4 24 | $411.3M | $256.6M | ||
| Q3 24 | $396.9M | $252.8M | ||
| Q2 24 | $360.1M | $244.7M | ||
| Q1 24 | $325.9M | $273.4M |
总债务APLSRVLV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSRVLV
| Q4 25 | $370.1M | $512.5M | ||
| Q3 25 | $401.2M | $490.2M | ||
| Q2 25 | $156.3M | $468.6M | ||
| Q1 25 | $164.2M | $453.4M | ||
| Q4 24 | $228.5M | $437.8M | ||
| Q3 24 | $237.1M | $420.8M | ||
| Q2 24 | $264.3M | $405.8M | ||
| Q1 24 | $266.7M | $389.9M |
总资产APLSRVLV
| Q4 25 | $1.1B | $765.0M | ||
| Q3 25 | $1.1B | $751.3M | ||
| Q2 25 | $821.4M | $722.9M | ||
| Q1 25 | $807.3M | $713.9M | ||
| Q4 24 | $885.1M | $665.5M | ||
| Q3 24 | $901.9M | $670.9M | ||
| Q2 24 | $904.5M | $657.8M | ||
| Q1 24 | $831.9M | $650.0M |
负债/权益比APLSRVLV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-13.3M |
| 自由现金流率自由现金流/营收 | -7.1% | -4.1% |
| 资本支出强度资本支出/营收 | 0.1% | 1.0% |
| 现金转化率经营现金流/净利润 | — | -0.55× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $48.0M |
8季度趋势，按日历期对齐
经营现金流APLSRVLV
| Q4 25 | $-14.2M | $-10.2M | ||
| Q3 25 | $108.5M | $11.8M | ||
| Q2 25 | $4.4M | $12.6M | ||
| Q1 25 | $-53.4M | $45.1M | ||
| Q4 24 | $19.4M | $3.9M | ||
| Q3 24 | $34.1M | $9.1M | ||
| Q2 24 | $-8.3M | $-24.7M | ||
| Q1 24 | $-133.0M | $38.4M |
自由现金流APLSRVLV
| Q4 25 | $-14.3M | $-13.3M | ||
| Q3 25 | $108.3M | $7.5M | ||
| Q2 25 | $4.4M | $10.4M | ||
| Q1 25 | $-53.4M | $43.4M | ||
| Q4 24 | $19.3M | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | $-8.4M | $-25.7M | ||
| Q1 24 | $-133.3M | $36.7M |
自由现金流率APLSRVLV
| Q4 25 | -7.1% | -4.1% | ||
| Q3 25 | 23.6% | 2.5% | ||
| Q2 25 | 2.5% | 3.4% | ||
| Q1 25 | -32.0% | 14.6% | ||
| Q4 24 | 9.1% | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | -4.2% | -9.1% | ||
| Q1 24 | -77.3% | 13.5% |
资本支出强度APLSRVLV
| Q4 25 | 0.1% | 1.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.2% | 0.6% |
现金转化率APLSRVLV
| Q4 25 | — | -0.55× | ||
| Q3 25 | 0.50× | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
